Animal studies have indicated that BPC-157 can reduce inflammatory markers and tissue damage associated with various inflammatory conditions
Here are some signs you have PA: Early signs of pernicious anemia Fatigue (many people wake up tired despite getting enough sleep) Shortness of breath Feeling dizzy Loss of appetite Diarrhea or constipation Lightheadedness when standing up or moving around Pale or yellow skin (in people of European ancestry) Heartburn Swollen tongue Long-term signs of pernicious anemia Short-term memory loss Trouble with balance (for example, struggling to put on your pants or socks while youre standing) Burning feeling in your legs or feet that may get worse at night Depression Trouble focusing and confusion Cold hands and feet Hallucinations Eyesight problems Pernicious anemia tongue About 25% of people with pernicious anemia have symptoms on their tongues
It is best to consult with a healthcare professional who can assess your specific situation and provide personalized recommendations
The Journal of hand surgery 33:102112 Kang EA, Han YM, An JM, Park YJ, Sikiric P, Kim DH, Kwon KA, Kim YJ, Yang D, Tchah H, Hahm KB (2018) BPC157 as potential agent rescuing from cancer cachexia
Risks and Safety Considerations Despite promising research, several important safety issues should be considered
Preclinical studies of Nrp1 including antibody blockades and genetic knockout models have been shown to reduce tumor growth and progression in prostate, lung, and skin cancers [140]
